MedPath

Thromboflux

Brand Name: Thromboflux

Generic Name: Streptokinase

Active
Registration Number

BR-1085

Dosage Form

Lyophilized Powder For Injection IV

Issuance Date

May 31, 2024

Expiry Date

September 21, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1,500,000IU
PackagingType I borosilicate clear glass vial with yellow green flip-off cap x 5 mL (Box of l's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-thrombotic Agent
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

StreptokinaseActive
Monograph: Streptokinase

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform